Physician
Medical Laboratory Services Medical Group INC
Medical Laboratory Services Medical Group INC was paid $496K by Medicaid between Jan 2018 and Sep 2022, across 89 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 13% of everything it billed.
33Billing provider infoMEDICAL LABORATORY SERVICES MEDICAL GROUP INC
MURRIETA, CA 92562
MURRIETA, CA 92562
33aNPI1427011576assigned 04/10/2006
33bProvider typeCytopathology Physician
28Total paid$496K
24GClaims281,865
24DCodes billed89
24AFirst – last monthJan 2018 – Sep 2022
Compared with peers
Next to other Cytopathology Physician providers in California
Rank by total paid#17 of 69
Median peer was paid$50K
This provider vs. median9.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 100,584 | $187K | |
| 2019 | 52,170 | $74K | |
| 2020 | 41,728 | $82K | |
| 2021 | 61,677 | $109K | |
| 2022 | 25,706 | $44K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 13% | 37,450 | 24,218 | $65K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11% | 42,333 | 28,165 | $54K |
| 88307 | 7.3% | 506 | 502 | $36K | |
| 82962 | 6.5% | 12,638 | 4,248 | $32K | |
| 87641 | 5.4% | 1,102 | 906 | $27K | |
| 81025 | 3.9% | 4,993 | 4,727 | $19K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.8% | 13,909 | 7,435 | $19K |
| 83735 | 3.5% | 15,572 | 7,861 | $18K | |
| 84484 | 3.3% | 9,639 | 8,240 | $17K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.3% | 462 | 443 | $16K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 202 | 195 | $14K |
| 83690 | 2.8% | 12,165 | 10,416 | $14K |
77 more codes
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.7% | 308 | $13K |
| 85730 | 1.9% | 9,439 | $9K | |
| 83880 | 1.8% | 1,557 | $9K | |
| 85027 | 1.8% | 8,236 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.8% | 6,604 | $9K |
| 85610 | 1.7% | 12,514 | $8K | |
| 87040 | 1.6% | 3,749 | $8K | |
| 83605 | 1.6% | 4,195 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 2,806 | $8K |
| 81003 | 1.3% | 17,557 | $7K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 364 | $6K |
| 81001 | 1.0% | 9,754 | $5K | |
| 85379 | <1% | 2,077 | $4K | |
| 84702 | <1% | 1,112 | $3K | |
| 87077 | <1% | 2,539 | $3K | |
| 80061 | Lipid panel | <1% | 1,604 | $3K |
| 84439 | <1% | 2,248 | $3K | |
| 87186 | <1% | 2,210 | $3K | |
| 86901 | <1% | 6,239 | $3K | |
| 84703 | <1% | 2,219 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 358 | $3K |
| 86900 | <1% | 5,889 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 371 | $3K |
| 86850 | <1% | 3,139 | $2K | |
| 84100 | <1% | 3,325 | $2K | |
| 84145 | <1% | 636 | $2K | |
| 88304 | <1% | 87 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,329 | $2K |
| 82550 | <1% | 2,006 | $2K | |
| 87070 | <1% | 1,261 | $2K | |
| 88342 | <1% | 32 | $2K | |
| 86140 | <1% | 1,534 | $1K | |
| 82248 | <1% | 1,817 | $1K | |
| 82247 | <1% | 1,583 | $1K | |
| 82533 | <1% | 393 | $1K | |
| 80202 | <1% | 471 | $1K | |
| 87275 | <1% | 955 | $1K | |
| 87276 | <1% | 953 | $996.73 | |
| 87081 | <1% | 738 | $708.83 | |
| 87210 | <1% | 215 | $663.37 | |
| 86141 | <1% | 336 | $635.05 | |
| 82140 | <1% | 263 | $628.38 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 45 | $583.52 |
| 86592 | <1% | 617 | $530.91 | |
| 85652 | <1% | 1,054 | $448.71 | |
| 80074 | <1% | 72 | $433.84 | |
| 86703 | <1% | 190 | $389.98 | |
| 87205 | <1% | 506 | $346.81 | |
| 87430 | <1% | 239 | $288.81 | |
| 86780 | <1% | 188 | $269.77 | |
| 84550 | <1% | 339 | $252.05 | |
| 82272 | <1% | 160 | $185.17 | |
| 85014 | <1% | 501 | $167.11 | |
| 82010 | <1% | 109 | $140.80 | |
| 85018 | <1% | 434 | $140.34 | |
| 86880 | <1% | 179 | $134.75 | |
| 85384 | <1% | 69 | $131.87 | |
| 84450 | <1% | 117 | $104.07 | |
| 82553 | <1% | 54 | $100.67 | |
| 82565 | <1% | 103 | $92.34 | |
| 83721 | <1% | 125 | $90.43 | |
| 82570 | <1% | 80 | $88.23 | |
| 83615 | <1% | 125 | $87.32 | |
| 83540 | <1% | 90 | $84.49 | |
| 83550 | <1% | 57 | $63.73 | |
| 84132 | <1% | 93 | $55.56 | |
| 84520 | <1% | 73 | $47.02 | |
| 87045 | <1% | 27 | $41.00 | |
| 86308 | <1% | 49 | $40.55 | |
| 87340 | <1% | 26 | $33.13 | |
| 87147 | <1% | 27 | $30.68 | |
| 86677 | <1% | 12 | $24.45 | |
| 80076 | <1% | 15 | $21.49 | |
| 84300 | <1% | 22 | $19.36 | |
| 84478 | <1% | 30 | $14.51 | |
| 87420 | <1% | 25 | $13.70 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLBURT, ERNEST (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Medical Laboratory Services Medical Group, INC. | Murrieta, CA | $1.24M |
| Medical Laboratory Services Medical Group, INC. | Wildomar, CA | $136K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.